Company Overview
CRINETICS PHARMACEUTICALS, INC.
CRNXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
8M
2025 FY
Net Income
-465M
2025 FY
Shares Outstanding
94M
2025 FY
EPS
-4.95USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1658247
Exchange
Nasdaq
Location
US